Literature DB >> 28447244

Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria.

Marc Sorigue1, Jordi Juncà2, Elisa Orna2, Nevena Romanic3, Edurne Sarrate4, Jordi Castellvi3, Montse Soler3, Ines Rodríguez-Hernandez2, Evarist Feliu2, Susana Ruiz3.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disorder associated with increased risk for thrombosis and reduced life expectancy. Retinal vein occlusion (RVO) is a frequent cause of vision loss but its relationship with PNH has not been studied systematically. Patients followed up for RVO in our ophthalmology department were screened for the presence of a PNH clone in peripheral blood by means of flow cytometry. The presence of other well-documented risk factors for RVO was also analyzed. In a series of 110 patients (54 males, median age of 67) we found no evidence of PNH. Most patients (97/110) had cardiovascular risk factors and/or hyperhomocysteinemia (67/110). Inherited thrombophilias were rare (three confirmed cases). Therefore, PNH does not appear to play a role in the development of RVO. However, this finding does not necessarily apply to young patients and/or those with no conventional risk factors for RVO, due to the low number of patients in these subgroups in our population.

Entities:  

Keywords:  Flow cytometry; Paroxysmal nocturnal hemoglobinuria; Retinal vein occlusion; Thrombophilia

Mesh:

Year:  2017        PMID: 28447244     DOI: 10.1007/s11239-017-1502-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  29 in total

1.  Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals.

Authors:  D J Araten; K Nafa; K Pakdeesuwan; L Luzzatto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Splanchnic vein thrombosis: new risk factors and management.

Authors:  Marco P Donadini; Francesco Dentali; Walter Ageno
Journal:  Thromb Res       Date:  2012-04       Impact factor: 3.944

3.  Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan.

Authors:  Paula Anne Newman-Casey; Maxwell Stem; Nidhi Talwar; David C Musch; Cagri G Besirli; Joshua D Stein
Journal:  Ophthalmology       Date:  2014-06-20       Impact factor: 12.079

4.  Central retinal vein occlusion and thrombophilia risk factors.

Authors:  Y P Adamczuk; M L Iglesias Varela; M E Martinuzzo; G S Cerrato; R R Forastiero
Journal:  Blood Coagul Fibrinolysis       Date:  2002-10       Impact factor: 1.276

Review 5.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

6.  PIG-A mutations in normal hematopoiesis.

Authors:  Rong Hu; Galina L Mukhina; Steven Piantadosi; Jamie P Barber; Richard J Jones; Robert A Brodsky
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

7.  Diagnosing PNH with FLAER and multiparameter flow cytometry.

Authors:  D Robert Sutherland; Nancy Kuek; Jeff Davidson; David Barth; Hong Chang; Erik Yeo; Sylvia Bamford; Ian Chin-Yee; Michael Keeney
Journal:  Cytometry B Clin Cytom       Date:  2007-05       Impact factor: 3.058

8.  Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories.

Authors:  Régis Peffault de Latour; Jean Yves Mary; Célia Salanoubat; Louis Terriou; Gabriel Etienne; Mohamad Mohty; Sophie Roth; Sophie de Guibert; Sebastien Maury; Jean Yves Cahn; Gerard Socié
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

9.  Thrombophilia and retinal vascular occlusion.

Authors:  Charles J Glueck; Robert K Hutchins; Joel Jurantee; Zia Khan; Ping Wang
Journal:  Clin Ophthalmol       Date:  2012-08-28

Review 10.  Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data.

Authors:  Petr Kolar
Journal:  J Ophthalmol       Date:  2014-06-09       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.